Navigation Links
InterMune Announces Senior Leadership Appointments to Prepare for Launch of Esbriet™ (Pirfenidone) in Europe
Date:12/17/2010

n the European headquarters in Basel, Switzerland and has worked in Switzerland, the UK, the US and Italy.  The following executives will report to Mr. Di Nepi.
  • Senior Vice President, EU Medical and Global Medical Advisor – Frank T. Weber, M.D.   Dr. Weber has 20 years of industry experience, having served most recently as Chief Medical Officer at Merck Serono where he played a key role in the registration and reimbursement processes in Europe for Erbitux® (cetuximab).  Dr. Weber previously served in various medical affairs positions at American Cyanamid/Lederle, Sythelabo and Merck KGaA.  He also worked on the national reimbursement side as Medical Director with MedNet, a Munich Re/United Health Care joint venture.  Dr. Weber began his career in healthcare as a surgeon and immunologist.  Dr. Weber has worked in Germany, Switzerland, France, the UK and the United States.  He will be based in the European headquarters in Basel, Switzerland.
  • Senior Vice President and General Manager, Germany – Markus Leyck Dieken, M.D. Dr. Dieken joins InterMune from Novartis, where he was Head of the European Region for the vaccines business and Managing Director of Novartis-Behring's German operations.  Prior to Novartis, he served for 10 years with Novo Nordisk Germany in various roles in Medical Affairs, Marketing and Sales, and then as General Manager of the German subsidiary and Vice President, Central Europe.  He has worked in Germany and Switzerland.  Dr. Leyck Dieken will be based in Berlin, Germany.  
  • Vice President, Sales and Marketing, Europe – Ms. Manuela Maronati.  Ms. Maronati brings 15 years of sales and marketing experience, including the past seven years with Amgen where she served as an International Senior Marketing Manager on the Neupogen® (filgrastim) franchise, and where she previously launched a new medical device f
    '/>"/>

  • SOURCE InterMune, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related biology technology :

    1. InterMune to Release Third Quarter Financial Results on October 28
    2. InterMune Sells Danoprevir Rights to Roche for $175 Million
    3. InterMune to Present at 2010 Citi Health Care Conference
    4. InterMune Receives FDA Complete Response Letter on Esbriet(TM) (Pirfenidone) New Drug Application
    5. InterMune to Release First Quarter Financial Results on April 29
    6. InterMune Announces Submission of MAA for Pirfenidone for the Treatment of Patients With IPF
    7. InterMune Announces Proposed Public Offering of Common Stock
    8. InterMune to Release Third Quarter Financial Results on November 5
    9. InterMune Announces Collaboration With National Jewish Health on NIH-Supported Genetic Research in Idiopathic Pulmonary Fibrosis
    10. InterMune to Present at Canaccord Adams Conference
    11. InterMune Reports Second Quarter 2009 Financial Results and Business Highlights
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/30/2014)... A study presented at the 2014 ... of CSL Behring,s C1 Inhibitor (C1-INH) concentrate in ... sensitized patients. C1-INH is a human protein and ... The study shows that post-transplant treatment with ... of complement components 3 and 4, suggesting that ...
    (Date:7/30/2014)... July 30, 2014 Sales Horizons, a ... of blended sales training programs for companies engaged in ... programs used by thousands of salespeople over 25 years ... training program can be customized to address the unique ... blended sales training program consists of two ...
    (Date:7/30/2014)... July 30, 2014 Vycom announces the ... products, designed to meet Factory Mutual (FM) 4910 fire ... such as wet benches, process tools, fume hoods, furniture ... and damage to semiconductor wafers used in electronic chip ... flame-retardant PVC solution with excellent workability and superior aesthetics. ...
    (Date:7/30/2014)... July 30, 2014   Epic Sciences, Inc. ... novel diagnostics to personalize and advance the treatment and ... Gregory T. Lucier as chairman of Epic,s board ... of Life Technologies (formerly Invitrogen). Mr. Lucier joins Epic,s ... its circulating rare cell analysis platform with special focus ...
    Breaking Biology Technology:Study Suggests C1-INH May Aid in Prevention of Antibody-Mediated Rejection Following Kidney Transplant 2Study Suggests C1-INH May Aid in Prevention of Antibody-Mediated Rejection Following Kidney Transplant 3Sales Horizons Launches New Blended Sales Training Programs to Companies Engaged in Complex B2B Sales 2Sales Horizons Launches New Blended Sales Training Programs to Companies Engaged in Complex B2B Sales 3Vycom Announces Flametec® Thermax PVC (FM4910 Listed) For a Variety of Clean Room Applications with Excellent Workability and Aesthetics 2Epic Sciences Appoints Greg Lucier as Chairman of the Board of Directors 2Epic Sciences Appoints Greg Lucier as Chairman of the Board of Directors 3
    ... Encorium Group, Inc. (Nasdaq: ENCO ... (CRO) that provides design, development, and management capabilities for ... world,s leading pharmaceutical companies, today announced the signing of ... both new business contracts and repeat business to be ...
    ... ETEX Corporation, a leading orthopaedic biomaterials company, ... 2.5cc sizes of Beta-bsm(TM) Injectable Paste and Gamma-bsm(TM) ... 10cc sizes. Both products are bone substitute materials ... (Logo: http://www.newscom.com/cgi-bin/prnh/20080424/NETH117LOGO ...
    ... Hospira, Inc. (NYSE: HSP ), a ... today that Brian Meadows has been named corporate ... will be responsible for enterprise-wide supply chain operations ... supplier management; procurement; materials and production planning; transportation ...
    Cached Biology Technology:Encorium Group Signs Approximately $2.0 Million of New Business Contracts 2Encorium Group Signs Approximately $2.0 Million of New Business Contracts 3ETEX Corporation Announces FDA Clearance of Small Size Beta-bsm(TM) Injectable Paste and Gamma-bsm(TM) Moldable Putty 2Hospira Names Brian Meadows Supply Chain Chief 2
    (Date:7/30/2014)... (OUP) is pleased to announce its new relationship with ... OUP and CINP will partner to publish International ... fully open-access journal. , Alan Frazer, Editor-in-Chief of ... and expertise of OUP will further facilitate the goal ... the very leading journals within neuropsychopharmacology. The conversion of ...
    (Date:7/30/2014)... $1 million from the Cornelia Cogswell Rossi Foundation to ... , The newly established Connie Cogswell Rossi ... a greater breadth and depth of knowledge of neurobehavioral ... of research to improve human health. , The new ... Laboratory and its external partners, supporting research to enhance ...
    (Date:7/30/2014)... Soon, protection from HIV infection could be as simple ... sex. , University of Washington bioengineers have discovered ... that protects women from contracting HIV. Their method spins ... in contact with moisture, releasing higher doses of the ... gels or creams. , "This could offer women a ...
    Breaking Biology News(10 mins):OUP to partner with the International College of Neuropsychopharmacology 2Rossi Foundation pledges $1M for JAX neurobehavioral research center 2Dissolvable fabric loaded with medicine might offer faster protection against HIV 2Dissolvable fabric loaded with medicine might offer faster protection against HIV 3
    ... chocolate or the bitter taste of strychnine would seem to ... be hard-wired into the brain. Indeed, in studies with the ... in the January 19, 2006, issue of Neuron experiments demonstrating ... favor a model for taste encoding in the brain that ...
    ... announced today a critical step on the path of realizing ... described in the April 21 issue of Cell, the researchers ... ES cells that help explain the cells' rare ability to ... appear near the master genes that control embryonic development and ...
    ... equal. They are separated into categories A through C, ... easy to spread, kill effectively and call for special ... worrisome organisms is anthrax, which has already received its ... Fischetti's laboratory at Rockefeller University suggests that a newly ...
    Cached Biology News:How taste response is hard-wired into the brain 2Novel molecular 'signature' marks DNA of embryonic stem cells 2Novel molecular 'signature' marks DNA of embryonic stem cells 3Newly discovered protein kills anthrax bacteria by exploding their cell walls 2
    Rat monoclonal [20d5] to NKG2A + C+ E ( Abpromise for all tested applications). Antigen: Tissue / cell preparation (Mouse): CHO transfected cells expressing the B6 allele of NKG2A. Entrez Gen...
    ... has recently launched a custom synthesis ... (siRNA). Thermos siRNA molecules are: ... 2 DNA bases overhang at the ... Delivered fully deprotected and ready-to-use. ...
    Rabbit polyclonal to STUB1 ( Abpromise for all tested applications). entrezGeneID: 10273 SwissProtID: Q9UNE7...
    ... orbital shaker stands both present ... ergonomic height, and help protect ... welded tubular steel, these heavy-duty ... the weight and minimize the ...
    Biology Products: